Literature DB >> 1643302

Rising case fatality of bacteriologically proven pulmonary tuberculosis in The Netherlands.

G de Meer1, H A van Geuns.   

Abstract

Analysis of registration cards from the Tuberculosis Control Program (TCP) showed a four-fold increase in case fatality of bacteriologically proven pulmonary tuberculosis in Dutch patients in the period 1973-1984. Registered data of 125 deceased patients whose primary cause of death was pulmonary tuberculosis were analyzed. Increased case fatality predominantly occurred in the elderly. Elderly patients presented often with other, less specific, complaints than coughing, but had a shorter combined patient's and doctor's delay than younger patients. The elderly were more often treated with 3 tuberculostatic drugs (INH, pyrazinamide, rifampin). Bacterial resistance was found in only 2%. Probably the most important factor concerning the raised case fatality in the elderly is the decline in immune response, due to ageing of the Dutch population. An effective response to tuberculostatic drugs needs a reasonably intact immune response. Declining immunity of the elderly group will increase incidence and mortality of pulmonary tuberculosis in this group.

Entities:  

Mesh:

Year:  1992        PMID: 1643302     DOI: 10.1016/0962-8479(92)90060-w

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  7 in total

1.  Rapid diagnosis of Mycobacterium tuberculosis bacteremia by PCR.

Authors:  L Folgueira; R Delgado; E Palenque; J M Aguado; A R Noriega
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

2.  Identification of a new DNA region specific for members of Mycobacterium tuberculosis complex.

Authors:  J Magdalena; A Vachée; P Supply; C Locht
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

3.  Rifampin increases cytokine-induced expression of the CD1b molecule in human peripheral blood monocytes.

Authors:  L Tentori; G Graziani; S A Porcelli; M Sugita; M B Brenner; R Madaio; E Bonmassar; A Giuliani; A Aquino
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

4.  Secular trends of tuberculosis in western Europe.

Authors:  M C Raviglione; P Sudre; H L Rieder; S Spinaci; A Kochi
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

5.  Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory.

Authors:  J E Clarridge; R M Shawar; T M Shinnick; B B Plikaytis
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

6.  Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study.

Authors:  Tuula Vasankari; Pekka Holmström; Jukka Ollgren; Kari Liippo; Maarit Kokki; Petri Ruutu
Journal:  BMC Public Health       Date:  2007-10-14       Impact factor: 3.295

7.  Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California.

Authors:  Robert J Blount; Lisa Pascopella; Donald G Catanzaro; Pennan M Barry; Paul B English; Mark R Segal; Jennifer Flood; Dan Meltzer; Brenda Jones; John Balmes; Payam Nahid
Journal:  Environ Health Perspect       Date:  2017-09-29       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.